2024year9month9, Lingtu signed an agreement with Beijing Boao Yihe Zekang Technology Co., Ltd. and established a joint laboratorylaboratory，All sample processing and testing services within China are provided by Beijing Boao Jingdian.

On September 30, 2000, Boao Biological Group Co., Ltd. was registered and established with the strong support of the State Council, the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Education, the Ministry of Health, and the Beijing Municipal Government. Initially relying on Tsinghua University, it was jointly established with Huazhong University of Science and Technology, the Chinese Academy of Medical Sciences, and the Academy of Military Medical Sciences.

Boao was co-founded by Tsinghua University's Academician Cheng Jing, who is the pioneer of gene detection chips in China. Boao has won the National Technology Invention Award twice in 2007 and 2018, the National Science and Technology Progress Award in 2023, and has been honored with the National Science and Technology Award three times.

Boao and its industrialization platforms have been granted over 700 patents domestically and internationally, with a patent conversion rate exceeding 50%.

As the chair and secretariat unit of the National Technical Committee for Standardization of Biochips, Boao has led the formulation of 17 national standards, 9 industry standards, and 2 group standards, all of which have been promulgated and implemented.

In October 2024, Lingtu and BoaoMillion Entrepreneurs Brain Health Projectreached a cooperation agreement. The Bob Miller Doctor Project customized exclusive training courses for Boao, guiding its partner doctors to use the FGA platform to intelligently formulate personalized nutritional prescriptions for Alzheimer's disease.

Alzheimer's disease is currently affecting over 50 million people worldwide. The diagnosis and treatment of AD still face enormous challenges. Patients are often diagnosed only when the disease has progressed to an advanced stage, such as when symptoms like memory loss appear. We also hope to help patients provide more effective management and control of the disease, offering more treatment options.

Bob Miller's personalized nutrition intervention course guided by functional genes integrates cutting-edge research in genomics, nutritional science, and environmental health, providing participants with a scientific and personalized prevention and intervention plan. The training course not only holds special value for the prevention and treatment of Alzheimer's disease but also has broad potential for health applications, helping to advance the development of precision medicine and personalized health management.

This course is designed to integrate functional genes with personalized nutritional intervention, helping doctors master personalized treatment methods for Alzheimer's disease to address increasingly complex aging issues and nutritional intervention needs.

This course discusses how to, in your clinical practice,

• explore the most promising and potential health management solutions for Alzheimer's Disease (AD)
• learn how to correctly identify Alzheimer's disease at the stage of minimal cognitive impairment or even before clinical symptoms appear through tests such as functional genes and biomarkers
• learn to prescribe personalized nutrition to prevent and treat the root causes of AD and maintain brain health

The following are partial screenshots of the course. If you are interested in this project, please click below toLearn More。